Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-07-07FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TYKERB (lapatinib) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2008-05-29Clinical Trial Update: Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract
This completed clinical trial evaluates laparoscopic ultrasound-guided tissue sampling in patients with cancers of the upper gastrointestina…
-
FDA approval · 2008-05-22FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech, Inc. The approval updates the product's labeling…
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer [Phase 2]
Phase 2 randomized trial comparing irinotecan plus capecitabine versus cisplatin plus capecitabine in patients with gastric cancer; the stud…
-
CLINICAL_TRIALS research · 2008-05-14Clinical Trial Update: Evaluation of Four Reconstructions After Total Gastrectomy [Phase 1]
Phase 1 clinical trial evaluating four reconstruction techniques after total gastrectomy in gastric cancer patients; current status is unkno…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of biweekly docetaxel in combination with capecitabine as first-line therapy for advanc…
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy [Phase 2]
Pfizer conducted a Phase 2 clinical trial of intravenous edotecarin in patients with advanced gastric cancer that progressed after chemother…
-
CLINICAL_TRIALS trial_result · 2008-03-25Clinical Trial Update: A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer [Phase 2]
A Phase II trial evaluated the combination of oxaliplatin with 5-fluorouracil and folinic acid in patients with gastric cancer; the study ha…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [Phase 2]
Phase II clinical trial evaluating Rituximab to suppress anti-mouse antibody and anti-toxin responses to the immunotoxin LMB-1 in several ca…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis [Phase 1]
A Phase I study evaluated continuous hyperthermic peritoneal perfusion with escalating doses of intraperitoneal platinum for gastrointestina…
-
FDA approval · 2008-01-18FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for HERCEPTIN (trastuzumab) from Genentech.
-
CLINICAL_TRIALS trial_result · 2008-01-11Clinical Trial Update: Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer [Phase 2]
Phase 2 neoadjuvant chemotherapy trial evaluating oxaliplatin, calcium folinate, and 5-fluorouracil for resectable advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2008-01-08Clinical Trial Update: S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer [Phase 2]
A Phase 2 trial comparing S-1 versus capecitabine in elderly and/or poor performance status patients with recurrent or metastatic gastric ca…
-
CLINICAL_TRIALS research · 2008-01-07Clinical Trial Update: Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer [Phase 2]
Phase II trial evaluating perioperative S-1 plus docetaxel in localized advanced gastric cancer; the update notes the study status as unknow…
-
CLINICAL_TRIALS research · 2008-01-07Clinical Trial Update: Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma [Phase 2]
A Phase 2 study assessing continuous or intermittent S-1 plus oxaliplatin for recurrent or metastatic gastric cancer; current status is unkn…
-
CLINICAL_TRIALS research · 2007-12-19Clinical Trial Update: Standard and Immunostimulating Enteral Nutrition in Surgical Patients [Phase 4]
The document reports completion of a Phase 4 clinical trial evaluating standard and immunostimulating enteral nutrition in surgical patients…
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: The Impact of Immunostimulating Nutrition on the Outcome of Surgery [Phase 4]
Phase 4 clinical trial assessing whether immunostimulating nutrition improves surgical outcomes in gastric and pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2007-09-14Clinical Trial Update: Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction [Phase 3]
Phase 3 trial of a bioresorbable membrane to reduce postoperative small bowel obstruction in gastric cancer has completed.
-
CLINICAL_TRIALS research · 2007-08-01Clinical Trial Update: Second-Line Irinotecan vs. ILF for AGC [Phase 2]
A Phase 2 trial update comparing second-line Irinotecan against the ILF regimen for advanced/metastatic gastric cancer.
-
CLINICAL_TRIALS trial_result · 2007-08-01Clinical Trial Update: Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC [Phase 2]
Phase 2 trial evaluating weekly docetaxel with cisplatin or oxaliplatin for advanced gastric cancer is summarized. The study targets stage I…
-
CLINICAL_TRIALS trial_result · 2007-07-31Clinical Trial Update: Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel in combination with UFT and leucovorin for advanced gastric cancer has completed.
-
CLINICAL_TRIALS research · 2007-07-25Clinical Trial Update: A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy [Phase 1]
This entry reports a Phase I trial evaluating S-1 with irinotecan and oxaliplatin for advanced gastrointestinal cancers, including colorecta…
-
CLINICAL_TRIALS trial_result · 2007-06-20Clinical Trial Update: Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer [Phase 2]
Phase 2 study of perioperative chemoradiotherapy for potentially resectable gastric cancer; status not reported.
-
CLINICAL_TRIALS trial_result · 2007-04-18Clinical Trial Update: Docetaxel and Capecitabine in Advanced Gastric Cancer [Phase 2]
Phase 2 trial update of docetaxel and capecitabine in advanced gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-18Clinical Trial Update: Irinotecan Versus Only Best Supportive Care for Gastric Cancer [Phase 3]
Phase 3 trial comparing irinotecan versus best supportive care for gastric cancer has completed, according to the update. No trial results a…